These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 25083859)

  • 1. Lack of genomic heterogeneity at high-resolution aCGH between primary breast cancers and their paired lymph node metastases.
    Vollebergh MA; Klijn C; Schouten PC; Wesseling J; Israeli D; Ylstra B; Wessels LF; Jonkers J; Linn SC
    PLoS One; 2014; 9(8):e103177. PubMed ID: 25083859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic profiling of oral squamous cell carcinoma by array-based comparative genomic hybridization.
    Yoshioka S; Tsukamoto Y; Hijiya N; Nakada C; Uchida T; Matsuura K; Takeuchi I; Seto M; Kawano K; Moriyama M
    PLoS One; 2013; 8(2):e56165. PubMed ID: 23457519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneity of PD-L1 expression in primary tumors and paired lymph node metastases of triple negative breast cancer.
    Li M; Li A; Zhou S; Xu Y; Xiao Y; Bi R; Yang W
    BMC Cancer; 2018 Jan; 18(1):4. PubMed ID: 29291717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic alterations in primary breast cancers compared with their sentinel and more distal lymph node metastases: an aCGH study.
    Wang C; Iakovlev VV; Wong V; Leung S; Warren K; Iakovleva G; Arneson NC; Pintilie M; Miller N; Youngson B; McCready DR; Done SJ
    Genes Chromosomes Cancer; 2009 Dec; 48(12):1091-101. PubMed ID: 19760610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Array comparative genomic hybridization analysis discloses chromosome copy number alterations as indicators of patient outcome in lymph node-negative breast cancer.
    Kikuchi-Koike R; Nagasaka K; Tsuda H; Ishii Y; Sakamoto M; Kikuchi Y; Fukui S; Miyagawa Y; Hiraike H; Kobayashi T; Kinoshita T; Kanai Y; Shibata T; Imoto I; Inazawa J; Matsubara O; Ayabe T
    BMC Cancer; 2019 May; 19(1):521. PubMed ID: 31146704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Classification of Lymph Node Metastases Subtypes Predict for Survival in Head and Neck Cancer.
    Huang L; David O; Cabay RJ; Valyi-Nagy K; Macias V; Zhong R; Wenig B; Feldman L; Weichselbaum R; Spiotto MT
    Clin Cancer Res; 2019 Mar; 25(6):1795-1808. PubMed ID: 30573692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ACGH detects distinct genomic alterations of primary intrahepatic cholangiocarcinomas and matched lymph node metastases and identifies a poor prognosis subclass.
    Jansen R; Moehlendick B; Bartenhagen C; Tóth C; Lehwald N; Stoecklein NH; Knoefel WT; Lachenmayer A
    Sci Rep; 2018 Jul; 8(1):10637. PubMed ID: 30006612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Array comparative genomic hybridisation (aCGH) analysis of premenopausal breast cancers from a nuclear fallout area and matched cases from Western New York.
    Varma G; Varma R; Huang H; Pryshchepava A; Groth J; Fleming D; Nowak NJ; McQuaid D; Conroy J; Mahoney M; Moysich K; Falkner KL; Geradts J
    Br J Cancer; 2005 Sep; 93(6):699-708. PubMed ID: 16222315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Criteria derived from serum markers can precisely evaluate axillary status in breast cancer patients.
    Wan H; Du Z; Long Q; Lü Q; Li H
    J Surg Res; 2017 Feb; 208():211-218. PubMed ID: 27993212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of DNA methylation profiling and copy number variation as indications of clonal relationship in ipsilateral and contralateral breast cancers to distinguish recurrent breast cancer from a second primary tumour.
    Huang KT; Mikeska T; Li J; Takano EA; Millar EK; Graham PH; Boyle SE; Campbell IG; Speed TP; Dobrovic A; Fox SB
    BMC Cancer; 2015 Oct; 15():669. PubMed ID: 26452468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An array CGH based genomic instability index (G2I) is predictive of clinical outcome in breast cancer and reveals a subset of tumors without lymph node involvement but with poor prognosis.
    Bonnet F; Guedj M; Jones N; Sfar S; Brouste V; Elarouci N; Banneau G; Orsetti B; Primois C; de Lara CT; Debled M; de Mascarel I; Theillet C; Sévenet N; de Reynies A; MacGrogan G; Longy M
    BMC Med Genomics; 2012 Nov; 5():54. PubMed ID: 23186559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative genomic analysis of primary tumors and metastases in breast cancer.
    Bertucci F; Finetti P; Guille A; Adélaïde J; Garnier S; Carbuccia N; Monneur A; Charafe-Jauffret E; Goncalves A; Viens P; Birnbaum D; Chaffanet M
    Oncotarget; 2016 May; 7(19):27208-19. PubMed ID: 27028851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TNM classification and the need for revision of pN3a breast cancer.
    van Nijnatten TJA; Moossdorff M; de Munck L; Goorts B; Vane MLG; Keymeulen KBMI; Beets-Tan RGH; Lobbes MBI; Smidt ML
    Eur J Cancer; 2017 Jul; 79():23-30. PubMed ID: 28458119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic profiling of submucosal-invasive gastric cancer by array-based comparative genomic hybridization.
    Kuroda A; Tsukamoto Y; Nguyen LT; Noguchi T; Takeuchi I; Uchida M; Uchida T; Hijiya N; Nakada C; Okimoto T; Kodama M; Murakami K; Matsuura K; Seto M; Ito H; Fujioka T; Moriyama M
    PLoS One; 2011; 6(7):e22313. PubMed ID: 21811585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of breast MRI for prediction of lymph node metastases - systematic approach using 17 individual descriptors and a dedicated decision tree.
    Dietzel M; Baltzer PA; Vag T; Gröschel T; Gajda M; Camara O; Kaiser WA
    Acta Radiol; 2010 Oct; 51(8):885-94. PubMed ID: 20735278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. St Gallen molecular subtypes in primary breast cancer and matched lymph node metastases--aspects on distribution and prognosis for patients with luminal A tumours: results from a prospective randomised trial.
    Falck AK; Fernö M; Bendahl PO; Rydén L
    BMC Cancer; 2013 Nov; 13():558. PubMed ID: 24274821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical relevance of biomarker discordance between primary breast cancers and synchronous axillary lymph node metastases.
    Janeva S; Parris TZ; Krabbe E; Sundquist M; Karlsson P; Audisio RA; Olofsson Bagge R; Kovács A
    Clin Exp Metastasis; 2023 Aug; 40(4):299-308. PubMed ID: 37392277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic change of chromosome 8 predicts the response to taxane-based neoadjuvant chemotherapy in node-positive breast cancer.
    Han S; Park K; Shin E; Kim HJ; Kim JY; Kim JY; Gwak G
    Oncol Rep; 2010 Jul; 24(1):121-8. PubMed ID: 20514452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metastatic progression of breast cancer: insights from 50 years of autopsies.
    Cummings MC; Simpson PT; Reid LE; Jayanthan J; Skerman J; Song S; McCart Reed AE; Kutasovic JR; Morey AL; Marquart L; O'Rourke P; Lakhani SR
    J Pathol; 2014 Jan; 232(1):23-31. PubMed ID: 24122263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-resolution genomic profiling to predict 10-year overall survival in node-negative breast cancer.
    Möllerström E; Delle U; Danielsson A; Parris T; Olsson B; Karlsson P; Helou K
    Cancer Genet Cytogenet; 2010 Apr; 198(2):79-89. PubMed ID: 20362222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.